J4

• 基础研究 • 上一篇    下一篇

黄芩总黄酮对S180、Hep-A-22和Bcap-37肿瘤细胞的抑制作用

绳 娟1,杨 振2,姜红柳1,洪 铁1   

  1. 1.吉林大学药学院药理学教研室,吉林 长春 130021;2.吉林省中医中药研究院,吉林 长春130021
  • 收稿日期:2007-08-30 修回日期:1900-01-01 出版日期:2008-05-28 发布日期:2008-05-28
  • 通讯作者: 洪 铁

Inhibitory effects of total flavonoids of scutellaria baicalensis georgi on S180, Hep-A-22 and Bcap-37 tumor cells

SHENG Juan1, YANG Zhen2, JIANG Hong-liu1, HONG Tie1   

  1. 1.Deptartment of Pharmacology, School of Pharmacy, Jilin University, Changchun 130021, China;2.Academy of Traditional Chinese Medicine and Materia Medica of Jilin Province, Changchun 130021, China
  • Received:2007-08-30 Revised:1900-01-01 Online:2008-05-28 Published:2008-05-28
  • Contact: HONG Tie

摘要: 目的:研究黄芩总黄酮对S180、Hep-A-22和Bcap-37肿瘤细胞增殖及S180和Hep-A-22荷瘤小鼠肿瘤生长的抑制作用。 方法:将S180、Hep-A-22和Bcap-37肿瘤细胞分别加入终浓度为12.5、25.0、50.0及100.0 mg•L-1的黄芩总黄酮,采用四氮唑盐衍生物(XTT)、MTT法测定细胞增殖抑制率;将S180和Hep-A-22荷瘤小鼠分为空白对照组、环磷酰胺(CTX)阳性药对照组(30 mg•kg-1,隔日给药)、黄芩总黄酮大(200 mg•kg-1•d -1)、中(100 mg•kg-1•d-1)和小剂量组(50 mg•kg-1•d-1),连续给药15 d后剥离肿瘤,称取瘤重,计算其 肿瘤生长的抑制率。观察各给药组Hep-A-22荷瘤小鼠连续用药10 d后生命延长率。结果:黄芩总黄酮对S180、Hep-A-22和Bcap-37肿瘤细胞的抑制率随给药浓度的增加而显著升高, 其IC50值分别为16.04、17.74和9.05 mg•L-1;与空白对照组比较,黄芩总黄酮大、中、小剂量组S180、Hep-A-22荷瘤小鼠的肿瘤重量均明显低于空白对照组(P<0.05或P<0.01),随给药剂量的增加,其肿瘤抑制率增加(P<0.05或P<0.01)。黄芩总黄酮大、中、小剂量组的Hep-A-22荷瘤小鼠的平均生存天数均显著高于空白对照组(P<0.01),其生命延长率较空白对照组显著增加(P<0.01)。结论:黄芩总黄酮对S180、Hep-A-22和Bcap-37肿瘤细胞的增殖及S180和Hep-A-22荷瘤小鼠肿瘤生长均具有抑制作用。

关键词: S180<, sub>, Hep-A-22, Bcap-37, 肿瘤抑制作用

Abstract: Abstract:Objective To study the inhibitory effects of total flavonoids of scutellaria baicalensis georgi (TFSB) on S180, Hep-A-22 and Bcap-37 tumor cell proliferation in vitro and on S180, Hep-A-22 in mice bearing tumor in vivo.Methods In vitro, S180, Hep-A-22 and Bcap-37 cells were divided into control group and TFSB groups (12.5,25.0,50.0,100.0 mg•L-1).The inhibitory effects of TFSB on proliferation of S180 and Hep-A-22 were measured by XTT colorimetric assay, and Bcap-37 cells were measured by MTT colorimetric assay.In vivo, the mice bearing tumor were divided into control group, CTX group (30 mg•kg-1),high, middle, low doses TFSB groups (200, 100,50 mg•kg-1).After the mice bearing S180 and Hep-A-22 tumor cells were treated with TFSB for 15 d, the tumor weights were measured, the inhibitory rates of S180 and Hep-A-22 were calculated and survival of Hep-A-22 was measured after administration of TFSB for 10 d.Results TFSB inhibited the proliferation of S180, Hep-A-22 and Bcap-37 cells, IC50 values were 16.04, 17.74 and 9.05 mg•L-1, respectively.The tumor weight of mice bearing S180 and Hep-A-22 cells in TFSB groups(200, 100, 50mg•kg-1) were lowered than that in control( P<0.01 or P<0.05). The tumor inhibitory rates were increased in dose-dependent manner.The survival of mice bearing Hep-A-22 in TFSB groups were higher than that in control(P<0.01 ).Conclusion TFSB may possess significantly inhibitory effect on proliferation of S180, Hep-A-22 and Bcap-37 cells in vitro and the growth of tumor in mice bearing S180 and Hep-A-22 in vivo.

Key words: S180<, sub>, Hep-A-22, Bcap-37

中图分类号: 

  • R965